accountNEW YORK (AdAge.com) -- PhRMA is advocating for a universal safety symbol -- either the FDA logo itself or an...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
DRUG MARKETING
Pharmaceutical companies are bombarding the airwaves with TV ads, showering doctors with gifts to get them to prescribe more of their drugs, and practicing other marketing tactics that can get them into hot water. The topic of drug marketing will examine the myriad ways the industry pushes its products -- and the inevitable controversies that result.
Drug Marketing is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
510 news
and
1,068 blog
items.
Read updated news, blogs, and resources about Drug Marketing. Find user-submitted articles and reactions on Drug Marketing from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
NEW YORK (AdAge.com) -- If supporters of health-care legislation seem like they're in a hurry to get a bill passed, it...
Dietary supplement sellers are trying to cash in on the frenzy over red wine.
A medical writing company uses questionable marketing practices.
The look-alike journals were funded by pharmaceutical clients including Merck, which is under investigation in the...
An informative article by Arlene Weintraub of BusinessWeek. Although many stories about resveratrol have been featured...
Dr. David Polly of the University of Minnesota is the second paid consultant to be snared by Sen. Charles Grassley's...
More than a dozen years ago, California became the first state to legalize medical marijuana for people with serious...
The Israeli generic-drug maker has an ambitious growth strategy.
Should a branded biotech get 5 years or 12 years of protection from generic competition?
Drugmakers may push for an overhaul of the U.S. health care system by spending $100 million on ads starting as early as...
Senator Charles E. Grassley, an Iowa Republican who has led a long-running investigation of conflicts of interest in...
The soon-to-merge drug giants have agreed to resolve a pending class action suit over their cholesterol drugs Vytorin...
Wharton professors weigh in on the pros and cons of the deal.
A recent New England Journal article examines the impact of a major legal case on drug marketing.
J&J and Amgen are among the companies that will have to revise product labels to reflect the risk.
A new bill would add further transparency to financial deals between pharmaceutical companies and doctors.
Big Pharma spent 8% less in '08 on drug advertising than it did the prior year--a rare pullback.
Merck & Co., facing more than 850 lawsuits over claims that its osteoporosis drug Fosamax may cause irreversible...
A family dropped its lawsuit after an anonymous donor paid them.
In F.D.A. Files, Claims of Rush to Approve Devices (January 13, 2009) F.D.A. Is Lax on Oversight During Trials, Inquiry...
Advisors to the FDA recommended banning Vicodin and Percocet.
Top Sources: Drug Marketing
- adage.com
- New York Times
- Reuters
- money.cnn.com
- online.wsj.com
- Chicago Tribune
- knowledge.wharton.upenn.edu
- medicinesocialjustice.blogspot.com
- blogs.nature.com
- carlatpsychiatry.blogspot.com
